Clinical Trials
83
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (69 trials with phase data)• Click on a phase to view related trials
The Performance of Different Sound Paths in Adult NeuroZti CI-users
- Conditions
- Cochlear ImplantHearing Loss, Bilateral or Unilateral
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Cochlear
- Target Recruit Count
- 20
- Registration Number
- NCT07033130
- Locations
- 🇫🇷
Cochlear Vallauris, Vallauris, France
Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array
- Conditions
- Sensorineural Hearing LossBilateral Hearing Loss
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Cochlear
- Target Recruit Count
- 19
- Registration Number
- NCT06936449
- Locations
- 🇺🇸
Rocky Mountain Ear Center, Englewood, Colorado, United States
An Investigation to Evaluate Sound Coding Enhancements in Adult Cochlear Implant Recipients
- Conditions
- Cochlear Implant RecipientsHearing Loss, Cochlear
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Cochlear
- Target Recruit Count
- 120
- Registration Number
- NCT06867380
- Locations
- 🇦🇺
HEARnet Clinical studies, Carlton, Victoria, Australia
🇦🇺Cochlear Melbourne, East Melbourne, Victoria, Australia
A Study to Evaluate the Safety and Performance of a Vestibular Implant in Adults to Provide Balance Restoration
- Conditions
- Moderate to Severe Hearing LossBalance DeficitsVestibulopathyNormal HearingVestibular Abnormality
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Cochlear
- Target Recruit Count
- 18
- Registration Number
- NCT06805175
- Locations
- 🇧🇪
ZAS Augustinus, Antwerp, Wilrijk, Belgium
🇪🇸C.H.U. Insular & Materno-Infantil Hospital.(SCS) Las Palmas University. (ULPGC), Avenida Marítima Del Sur, Las Palmas De Gran Canaria, Spain
🇪🇸Clinica Universitad de Navarra (CUN), Pamplona, Navarre, Spain
A Study to Explore Improved Features and a Simplified Treatment Approach for a Totally Implantable Cochlear Implant (TICI) Research System in Adults with Severe Hearing Loss
- Conditions
- Hearing Loss, Bilateral or UnilateralHearing Loss, SensorineuralHearing Loss, Cochlear
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Cochlear
- Target Recruit Count
- 12
- Registration Number
- NCT06642935
- Locations
- 🇦🇺
Royal Victoria Eye and Ear Hospital, Melbourne, Victoria, Australia
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
News
PolyActiva Secures $40M Series C to Advance Revolutionary Glaucoma Implant Technology
Melbourne-based PolyActiva raised $40 million in Series C funding, including $27 million from Australia's National Reconstruction Fund, to advance its biodegradable glaucoma treatment implant.